WCM
AMED

WealthBridge Capital Management’s Amedisys AMED Stock Holding History

WealthBridge Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-36
Closed -$4K – 137
2019
Q1 		$4K Sell
36
-2
-5% -$251 ﹤0.01% 706
2018
Q4 		$4K Buy
+38
New +$4.48K ﹤0.01% 667

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

WealthBridge Capital Management's AMED Position: Q2 2019 in Review

WealthBridge Capital Management sold out of Amedisys (AMED) in Q2 2019, closing a stake of 36 shares — an estimated $4K sold.

WealthBridge Capital Management first reported a position in AMED in Q4 2018 and held it in 2 quarters. The position peaked at $4K in Q1 2019. 285 funds tracked by Wall St. Rank hold AMED as of Q2 2019.

  • WealthBridge Capital Management reported no remaining Amedisys position as of Q2 2019 after selling out during the quarter.
  • WealthBridge Capital Management sold 36 Amedisys shares in Q2 2019, an estimated $4K.
  • WealthBridge Capital Management first reported a position in Amedisys in Q4 2018 and held it in 2 quarters.
  • WealthBridge Capital Management's Amedisys position peaked at $4K in Q1 2019.
  • 285 funds tracked by Wall St. Rank held Amedisys as of Q2 2019.

Based on WealthBridge Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.